A detailed history of Rothschild Investment LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 55 shares of KYMR stock, worth $2,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55
Previous 15 266.67%
Holding current value
$2,802
Previous $448,000 481.03%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$30.16 - $52.4 $1,206 - $2,096
40 Added 266.67%
55 $2.6 Million
Q2 2024

Jul 30, 2024

BUY
$29.85 - $39.42 $447 - $591
15 New
15 $448,000
Q1 2024

Jul 31, 2024

SELL
$22.9 - $43.57 $229 - $435
-10 Reduced 66.67%
5 $201,000

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.79B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.